filgrastim bs inj. 75mcg syringe "nig" (フィルグラスチムbs注75μgシリンジ「nig」)
nichi-iko pharmaceutical co.,ltd - filgrastim(genetical recombination) [filgrastim biosimilar 2] - injection
filpegla 6 mg 0.6 ml solution for injection in pre-filled syringe
cipla malaysia sdn bhd - pegfilgrastim -
neupogen pre-filled syringe 48 mu0.5 ml
amgen biotechnology singapore pte ltd - filgrastim - injection - 48 mu/0.5 ml - filgrastim 48 mu/0.5 ml
neupogen injection 300 mcgml
amgen biotechnology singapore pte ltd - filgrastim - injection - 300 mcg/ml - filgrastim 300 mcg/ml
neupogen injection 480 mcg1.6 ml
amgen biotechnology singapore pte ltd - filgrastim - injection - 480 mcg/1.6 ml - filgrastim 480 mcg/1.6 ml
neulastim pre-filled syringe 6mg0.6ml
amgen biotechnology singapore pte ltd - pegfilgrastim - injection, solution - 6mg - pegfilgrastim 6mg/0.6ml
pelmeg
mundipharma corporation (ireland) limited - pegfilgrastim - neutropenia - immunostimulants, - to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy.
ziextenzo
sandoz gmbh - pegfilgrastim - neutropenia - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
nyvepria
pfizer europe ma eeig - pegfilgrastim - neutropenia - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
fulphila 6 mg 0.6 ml solution for injection
biocon sdn bhd - pegfilgrastim -